ArticleJCEM case reports2026
Complete pathologic necrosis of a thyroid neoplasm following pressure-enabled thyroid artery embolization.
Article in JCEM case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thyroid nodules are increasingly detected with advanced imaging. Although most are benign, accurate preoperative risk stratification remains essential. Fine-needle aspiration is central to evaluation, yet Bethesda III nodules remain challenging because of the variable malignancy risk. Thyroid carcinoma generally has a favorable prognosis, but certain molecular subtypes are associated with higher mortality. Therefore, surgical resection remains the standard treatment for indeterminate and malignant thyroid tumors. However, the thyroid's rich vascular supply, along with comorbidities and factors such as age and mediastinal extension, can increase operative risk. Preoperative transarterial embolization has emerged as an adjunct to reduce tumor vascularity and improve surgical outcomes. We report a case of a 72-year-old African American male with multiple comorbidities who presented with an indeterminate thyroid neoplasm harboring a
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.